Specialty Enzymes - About the company
Specialty Enzymes is an unfunded company based in Chino (United States), founded in 2002. It operates as a Manufacturer of enzymes and probiotics for nutraceutical applications. Specialty Enzymes has not raised any funding yet. The company has 4426 active competitors, including 125 funded and 332 that have exited. Its top competitors include companies like Abbott, WuXi AppTec and Precision Medicine Group.
Company Details
Manufacturer of enzymes and probiotics for nutraceutical applications. It provides branded products and custom formulations for dietary supplements, mixes, and protein powders. The company offers a wide selection of individual enzymes and probiotics, as well as proprietary blends. Manufacturing takes place in GMP-certified facilities, with rigorous testing in ISO-17025 certified labs. Technical sales support is available to assist clients in developing optimal solutions.
- Website
- specialtyenzymes.com
Key Metrics
Founded Year
2002
Location
Chino, United States
Stage
Unfunded
Ranked
170th among 4426 active competitors
Employee Count
54 as on Aug 31, 2026
Sign up to download Specialty Enzymes' company profile
Specialty Enzymes's funding and investors
Specialty Enzymes has not raised any funding rounds yet.
Specialty Enzymes' founders and board of directors
Founder? Claim ProfileSpecialty Enzymes' employee count trend
Specialty Enzymes has 54 employees as of Aug 26. Here is Specialty Enzymes's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Specialty Enzymes's Competitors and alternates
Top competitors of Specialty Enzymes include Abbott, WuXi AppTec and Precision Medicine Group. Here is the list of Top 10 competitors of Specialty Enzymes, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Abbott 1888, Libertyville (United States), Public | Developer of medical devices, generic pharmaceuticals, and nutrition products | - | 76/100 | |
2nd | WuXi AppTec 2000, Shanghai (China), Public | Provider of CRO and CDMO services | $40M | 75/100 | |
3rd | Precision Medicine Group 2012, Bethesda (United States), Late Stage | Provider of clinical research, development, and commercialization services for life sciences | $532M | 72/100 | |
4th | ANI Pharmaceuticals 1996, Baudette (United States), Public | Manufacturer of pharmaceutical products, including extended-release capsules and immediate-release tablets | - | 64/100 | |
5th | Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes | - | 63/100 | ||
6th | Neolife 1958, Fremont (United States), Unfunded | Provider of whole food nutritional supplements | - | - | 62/100 |
7th | Zuellig Pharma 1992, Singapore (Singapore), Funding Raised | Provider of clinical research, quality management, logistics, and clinical trial supply services | - | 61/100 | |
8th | Eurofins Scientific 1987, Luxembourg (Luxembourg), Public | Provider of laboratory testing services and CRO contract research services | - | 61/100 | |
9th | CDMO focused on manufacturing of plant based pharma, nutraceuticals, cosmetics, and other products | - | 60/100 | ||
10th | Herbalife 1980, Los Angeles (United States), Public | Manufacturer of nutritional supplement products for multiple therapeutic conditions | - | 60/100 | |
170th | ![]() Specialty Enzymes 2002, Chino (United States), Unfunded | Manufacturer of enzymes and probiotics for nutraceutical applications | - | - | 38/100 |
Looking for more details on Specialty Enzymes's competitors? Click here to see the top ones
Specialty Enzymes's Investments and acquisitions
Specialty Enzymes has made no investments or acquisitions yet.
Reports related to Specialty Enzymes
Here is the latest report on Specialty Enzymes's sector:
News related to Specialty Enzymes
Media has covered Specialty Enzymes for a total of 3 events in the last 1 year, 2 of them have been about company updates.
•
Specialty Enzymes & Probiotics Launches SlimSEB™ for Cardiometabolic Wellness and Weight ManagementPR Newswire•Sep 03, 2026•Specialty Enzymes
•
Bacillus clausii 088AE is the first VHP-listed B. clausii for dogsPR Newswire•Jun 04, 2026•Specialty Enzymes
•
Pepzyme AG™ Supercharges Collagen Breakdown for GLP-1 SupportPR Newswire•Jan 26, 2026•Specialty Enzymes
•
Specialty Enzymes & Probiotics Publishes New Clinical Study on Revolutionary Sports Nutrition Ingredient DigeSEB Sport™PR Newswire•Apr 17, 2024•Specialty Enzymes
•
•
•
•
SEBiotic™ Receives No Objections Letter from FDA for GRAS SubmissionPR Newswire•Feb 24, 2021•Specialty Enzymes
•
Specialty Enzymes & Probiotics Earns Non-GMO Project VerificationPR Newswire•Apr 20, 2020•Specialty Enzymes
•
Global Enzymes for Agriculture Market 2018 – BASF, Creative Enzyme, Specialty Enzymes & Biotechnologies, Aum Enzymetruthweek.com•Dec 10, 2018•BASF, Creative Enzymes, Specialty Enzymes, Aumenzymes
Are you a Founder ?
FAQs about Specialty Enzymes
Explore our recently published companies
- Frukt AS - Norway based, Unfunded company
- Ojha Sir Gyanshala - Unfunded company
- Ozeku - Unfunded company
- Mainmeditech - China based, 2020 founded, Unfunded company
- MOBYLIZ - France based, 2020 founded, Unfunded company
- Dave Carmack - Unfunded company
